CDC Solutions Sponsors Worldwide Survey into Global Regulatory Submissions Trends.

Business Editors/High-Tech Writers

PHILADELPHIA & CHIPPENHAM, U.K.--(BUSINESS WIRE)--Dec. 3, 2002

Thousands of Pharmaceutical Professionals Are Targeted to Participate

in This Exclusive and Pioneering Program to Produce the Premier

Benchmark of Global Regulatory Submissions Trends

CDC Solutions Ltd. (CDC) (www.cdcsolutions.com), the leading global provider of document-based solutions to the life sciences industries, today announced that it is conducting a comprehensive survey into global regulatory submissions trends, which is a world-first in its field.

The survey is now well underway and receiving an outstanding response from the life sciences industries.

This new survey: Regulatory Submissions Trends Survey 2002, targets thousands of professionals in the life sciences sector across Europe and the USA and was commissioned by CDC Solutions in October this year to provide a balanced perspective into how regulatory departments are using technology today and how they plan to harness technology in the future.

This extensive survey of the submissions market concentrates on three key areas: technology usage trends, submissions outsourcing trends and regulatory trends. It is intended to provide an exclusive insight into the emerging and future trends of submissions technologies for each of the life sciences segments, e.g. pharmaceutical, biotechnology and medical devices.

Ellen Semple is Global VP of Marketing at CDC Solutions and is driving this worldwide initiative that further extends CDC Solutions's position as a technology leader in the life sciences sector. "At CDC Solutions, we are dedicated to clearly understanding and meeting the continually emerging demands that are specific to regulatory publishing within the life sciences sector. The market has rewarded this focus; with CDC bringing it's innovative solutions to 21 new pharmaceutical clients in the past year. To build upon our leadership position this survey creates an ongoing dialogue with the global market and advances our understanding of its distinct needs."

Ellen continues, "This survey, which CDC Solutions will execute annually, will provide us with the insight that will help our clients and prospects understand emerging trends, and help CDC respond to our clients' and prospects' emerging needs."

CDC Solutions is the first company in the life sciences market to invest in such an approach to understand market needs and to establish a critical benchmark for emerging market trends.

The summary of findings, which is expected to be distributed early in the New Year, is already attracting interest from regulatory affairs professionals, publishers and conference organisers, as it will provide an insightful overview of global submission trends. Contributors to the report, who responded to the 23 questions within the survey, will receive a complimentary summary report.

So far, the take up has exceeded all expectations highlighting the timeliness and significance of the report findings.

For more information on the survey, its findings and publishing timescales please contact Ellen Semple in the USA, e-mail [e-mail] or Alison Matthews in the UK, e-mail [e-mail]. Editors and writers are invited to liaise with our PR team, listed at the top of this release. Alternatively, visit www.cdcsolutions.com.

About CDC Solutions Ltd.

Founded in 1994, CDC Solutions is the leader in high performance document-based solutions to the Life Sciences industries. The open, flexible technologies developed by CDC Solutions enable Life Sciences companies to meet the strict standards of regulatory authorities across the world, helping them achieve quality, accuracy, and data integrity to deliver reports and submissions reliably on time.

CDC Solutions helps compress the regulatory submissions and approval process, improving speed to market, cost control, and productivity: all of which contribute to ensuring patients' and physicians' timely access to new drugs.

CDC Solutions develops products in-house, employing a team of developers and regulatory specialists who actively pilot new initiatives with clients and partners. Through its strategic business partners, CDC Solutions' technology is used to address the needs of other document intensive industries such as engineering, utilities, and finance.

For more information, call [phone] (United Kingdom) or +1 610.834.9021 (CDC Solutions Inc., North America), or visit the CDC Solutions website at www.cdcsolutions.com.

CDC Solutions, EZsubs, PDFfusion, PDFrender, PDFaqua, PDFcontrol, Xtensia, Xssembler, and Xport are trademarks or registered trademarks, service marks or registered service marks of CDC Solutions Ltd. All other product and company names mentioned herein may be trademarks of their respective holders.